STI-9199
- Generic Name
- STI-9199
Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2023-02-13
- Lead Sponsor
- Sorrento Therapeutics, Inc.
- Registration Number
- NCT05372783
- Locations
- 🇺🇸
ProSciento, Inc., Chula Vista, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath